Catalyst Wire Dossier Catalyst Wire Dossier

KMB-17

live attenuated mumps vaccine (F-genotype) in human diploid cell · Institute of Medical Biology, Chinese Academy of Medical Sciences
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KMB-17, covering 2023-10-11 to 2023-10-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase II/III of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Healthy Children Aged 5-11 [Phase 2, Phase 3]

See pricing